APA (7th ed.) Citation

S, C., R, B., R, L., S, S., A, F., E, A., . . . (GISCAD), I. G. f. t. S. o. D. T. C. (2008). Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: A randomised, multicentre, phase II trial. Lancet Oncology, 9(1), 39. https://doi.org/10.1016/s1470-2045(07)70383-2

Chicago Style (17th ed.) Citation

S, Cascinu, et al. "Cetuximab Plus Gemcitabine and Cisplatin Compared with Gemcitabine and Cisplatin Alone in Patients with Advanced Pancreatic Cancer: A Randomised, Multicentre, Phase II Trial." Lancet Oncology 9, no. 1 (2008): 39. https://doi.org/10.1016/s1470-2045(07)70383-2.

MLA (9th ed.) Citation

S, Cascinu, et al. "Cetuximab Plus Gemcitabine and Cisplatin Compared with Gemcitabine and Cisplatin Alone in Patients with Advanced Pancreatic Cancer: A Randomised, Multicentre, Phase II Trial." Lancet Oncology, vol. 9, no. 1, 2008, p. 39, https://doi.org/10.1016/s1470-2045(07)70383-2.